17 May 2024
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
Impact on practice presented by Davide Capodanno
Summary
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al. J Am Coll Cardiol. 2021;77:2204-2215
- IDEAL-LM: Van Geuns, et al. EuroPCR 2024, Paris
- BIOADAPTOR : Saito S, et al. EuroPCR 2024, Paris
- BIO ASCEND ISR: Chen Y, et al. EuroIntervention. 2024 [ePub ahead of print]
- IRONMAN-II Trial: Song L, et al. Presented at EuroPCR 2024, Paris
- DESyne BDS Plus: Abizaid A, et al. Presented at EuroPCR 2024, Paris
- ABILITY DM GLOBAL: Abizaid A, et al. Presented at EuroPCR 2024, Paris
- REC-CAGEFREE II Trial: Tao L, et al. Presented at EuroPCR. Paris, May 15, 2024
- LANDMARK Trial: Serruys PW, et al. Presented at EuroPCR. Paris, May 15, 2024
- NOTION-2 Trial: De Backer O, et al. Presented at EuroPCR. Paris, May 15, 2024
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide026.jpg)
/slide027.jpg)
/slide028.jpg)
/slide029.jpg)
/slide030.jpg)
/slide031.jpg)
/slide032.jpg)
/slide033.jpg)
/slide034.jpg)
